mepenzolate has been researched along with physostigmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Guede-Guina, F; Ochillo, RF; Smith, MO; Tsai, CS; Vangah-Manda, M | 1 |
1 review(s) available for mepenzolate and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for mepenzolate and physostigmine
| Article | Year |
|---|---|
Isolation of cholinergic active ingredients in aqueous extracts of Mareya micrantha using the longitudinal muscle of isolated guinea-pig ileum as a pharmacological activity marker.
Topics: Acetylcholine; Animals; Benzilates; Chemical Fractionation; Cholinergic Agents; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscarine; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Physostigmine; Piperidines; Plant Extracts; Water | 1995 |